20933 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals p53
PHYSIOLOGICALLY ACTIVE SUBSTANCE CARRIER
#2Probiotic method and composition for maintaining a healthy vaginal microbiome
#3HYBRID GOLD NANOPARTICLE-LIPID NANOPARTICLES AND METHODS OF USE AND PRODUCTION THEREOF
#4Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
#5Modulation of an Individual's Gut Microbiome to Address Osteoporosis and Bone Disease
#6Topical application to treat acne vulgaris
#7USING MINIVECTORS TO TREAT IDIOPATHIC PULMONARY FIBROSIS
#8COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS
#9Physiologically active substance carrier
#10Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
#11Method and system for modulating an individual's skin microbiome
#12METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING CANCER
#13Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
#14Probiotic method and composition for maintaining a healthy vaginal microbiome
#15Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells
#16Modulation of an individual's gut microbiome to address osteoporosis and bone disease
#17Probiotic to enhance an individual's skin microbiome
#18Topical application of CRISPR-modified bacteria to treat acne vulgaris
#19TREATMENT OF LIVER CANCER OR LIVER FIBROSIS
#20Method and system for reducing the likelihood of developing depression in an individual
#21CELL-DERIVED VESICLES COMPRISING WILD-TYPE P53 PROTEIN FOR ANTIVIRAL THERAPY
#22Topical application of to ameliorate barrier damage and inflammation
#23Method and system for reducing the likelihood of osteoporosis
#24Method for treating individuals having cancer and who are receiving cancer immunotherapy
#25Method for treating an individual suffering from bladder cancer
#26Method and system for reducing the likelihood of developing colorectal cancer in an individual human being
#27Method and System for Reducing the Likelihood of Developing Depression in an Individual
#28Method and System to Improve the Health of a Person's Skin Microbiome
#29METHODS FOR TREATING CANCER
#30Physiologically active substance carrier
#31Method for treating an individual suffering from a chronic infectious disease and cancer
#32Small Molecule Cancer Treatments that Cause Necrosis in Cancer Cells But Do Not Affect Normal Cells
#33Method for reducing the likelihood of developing bladder or colorectal cancer in an individual human being
#34Method and system for reducing the likelihood of osteoporosis
#35Method and system for reducing the likelihood of developing depression in an individual
#36Methods and compositions for preventing or treating cancer
#37Method for reducing the likelihood of developing cancer in an individual human being
#38Reducing the likelihood of skin cancer in an individual human being
#39Methods for reducing side effects of immunotherapy
#40SMALL MOLECULE CANCER TREATMENTS THAT CAUSE NECROSIS IN CANCER CELLS BUT DO NOT AFFECT NORMAL CELLS
#41Physiologically active substance carrier
#42Protein Hydrogels For Treatment Of Neovascular Disease
#43Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
#44Method of reducing the likelihood of skin cancer in an individual human being
#45Cell-penetrating peptide
#46COMPOSITIONS, ASSAYS, AND METHODS FOR TARGETING HDM2 AND HDMX TO REVERSE THE INHIBITION OF p53 IN PEDIATRIC CANCERS
#47Methods and compositions for preventing or treating cancer
#48COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY AND IMMUNE CHECKPOINT BLOCKADE FOR THE TREATMENT OF CANCER
#49Method of reducing the likelihood of skin cancer in an individual human being
#50Oncological and Neurological Therapy based on ATM, CHK2 and p53 proteins for DNA correction of transcription errors
#51Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
#52Method and system for treating cancer cachexia
#53Method of reducing the likelihood of skin cancer in an individual human being
#54USE OF ANTIBODY CONJUGATES
#55OLIGOMERIZATION DOMAIN OF P53 TO BYPASS THE DOMINANT-NEGATIVE EFFECT OF MUTANT
#56Method and system for treating cancer cachexia
#57Methods for DNA-dependent targeting of a cell permeant antibody
#58Compositions comprising serum albumin and p53 peptides fusion proteins
#59Compositions and methods involving endogenous retrovirus proteins
#60Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
#61PEPTIDE ABLE TO DISRUPT THE PROTEIN COMPLEX BETWEEN THE HIS273 MUTADED P53 PROTEIN AND THE ONCOSUPPRESSIVE P73 PROTEIN IN TUMOR CELLS AND THERAPEUTIC USES THEREOF
#62Downregulation of SPY1 by p53 as an essential component of p53-mediated effects
#63Small molecule cancer treatments that cause necrosis in cancer cells but do not affect normal cells
#64Anticancer Agent to Be Combined with Telomelysin
#65Use of Antibody Conjugates
#66Recombinant gene of adenovirus vector and p53 gene for treating proliferative diseases
#67TREATMENT OF RHEUMATOID ARTHRITIS WITH SOLUBLE FAS-LIGAND CROSS-LINKERS
#68THERAPY FOR CELLULAR ACCUMULATION IN CHRONIC INFLAMMATORY DISEASES
#69Nucleic acid delivery
#70Compositions and methods for inhibiting cell senescence and hyperproliferative disorders
#71Treatment of rheumatoid arthritis with soluble Fas-ligand cross-linkers
#72Nucleic acid delivery